News

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

The cochlear implant team at MUSC Health adds a new clinical trial that’s testing a device that may reduce hearing loss that can happen as an implant goes in.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.

The U.S. surgeon general is calling attention to the link between alcohol and cancer, a connection that may be news to the general public.

As doctors in emergency department see more signs patients have been vaping, they focus on what might help kids kick habit.

On World Pancreatic Cancer Day, researchers and survivors gathered to share progress in the fight against pancreatic cancer.

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

MUSC receives one of 27 HRSA grants nationwide that seek to leverage telehealth to improve behavioral health in rural communities.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.